ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis
Arthritis & Rheumatism
◽
10.1002/art.38042
◽
2013
◽
Vol 65
(9)
◽
pp. 2486-2496
◽
Cited By ~ 74
Author(s):
Daniel J. Lovell
◽
Edward H. Giannini
◽
Andreas O. Reiff
◽
Yukiko Kimura
◽
Suzanne Li
◽
...
Keyword(s):
Juvenile Idiopathic Arthritis
◽
Systemic Juvenile Idiopathic Arthritis
◽
Safety And Efficacy
Download Full-text
Related Documents
Cited By
References
2.1 Long-term safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis (JIA)
Pediatric Rheumatology
◽
10.1186/1546-0096-6-s1-s1
◽
2008
◽
Vol 6
(S1)
◽
Cited By ~ 2
Author(s):
S Yokota
◽
T Imagawa
◽
T Miyamae
◽
K Kasai
◽
M Mori
◽
...
Keyword(s):
Juvenile Idiopathic Arthritis
◽
Systemic Juvenile Idiopathic Arthritis
◽
Safety And Efficacy
Download Full-text
Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
Case Medical Research
◽
10.31525/ct1-nct03932344
◽
2019
◽
Author(s):
Keyword(s):
Juvenile Idiopathic Arthritis
◽
Systemic Juvenile Idiopathic Arthritis
◽
Safety Study
Download Full-text
PReS-FINAL-2166: Long-term safety and effectiveness of anti-interleukin-6 receptor monoclonal antibody, tocilizumab, in patients with systemic juvenile idiopathic arthritis in Japan
Pediatric Rheumatology
◽
10.1186/1546-0096-11-s2-p178
◽
2013
◽
Vol 11
(S2)
◽
Cited By ~ 1
Author(s):
S Yokota
◽
T Nozawa
◽
T Kanetaka
◽
K Yamazaki
◽
T Sato
◽
...
Keyword(s):
Monoclonal Antibody
◽
Juvenile Idiopathic Arthritis
◽
Interleukin 6
◽
Systemic Juvenile Idiopathic Arthritis
◽
Interleukin 6 Receptor
◽
Receptor Monoclonal Antibody
Download Full-text
Long-term safety and efficacy of abatacept in children with juvenile idiopathic arthritis
Arthritis & Rheumatism
◽
10.1002/art.27431
◽
2010
◽
Vol 62
(6)
◽
pp. 1792-1802
◽
Cited By ~ 151
Author(s):
Nicolino Ruperto
◽
Daniel J. Lovell
◽
Pierre Quartier
◽
Eliana Paz
◽
Nadina Rubio-Pérez
◽
...
Keyword(s):
Juvenile Idiopathic Arthritis
◽
Safety And Efficacy
Download Full-text
THU0579 Treating To Target with Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis: Results from The Long-Term Extension The Phase III Pivotal Trial
Annals of the Rheumatic Diseases
◽
10.1136/annrheumdis-2016-eular.2658
◽
2016
◽
Vol 75
(Suppl 2)
◽
pp. 401.2-402
◽
Cited By ~ 1
Author(s):
N. Ruperto
◽
H.I. Brunner
◽
P. Quartier
◽
T. Constantin
◽
E. Alexeeva
◽
...
Keyword(s):
Juvenile Idiopathic Arthritis
◽
Systemic Juvenile Idiopathic Arthritis
◽
Phase Iii
◽
Pivotal Trial
Download Full-text
2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA)
Pediatric Rheumatology
◽
10.1186/1546-0096-6-s1-s2
◽
2008
◽
Vol 6
(S1)
◽
Cited By ~ 5
Author(s):
N Ruperto
◽
◽
P Quartier
◽
N Wulffraat
◽
P Woo
◽
...
Keyword(s):
Monoclonal Antibody
◽
Juvenile Idiopathic Arthritis
◽
Phase Ii
◽
Phase Ii Trial
◽
Systemic Juvenile Idiopathic Arthritis
◽
Safety And Efficacy
◽
Efficacy Profile
Download Full-text
AB1172 Safety and efficacy of a 12-MO canakinumab administration in patients with systemic juvenile idiopathic arthritis: Data from the greek national registry
Annals of the Rheumatic Diseases
◽
10.1136/annrheumdis-2012-eular.1170
◽
2013
◽
Vol 71
(Suppl 3)
◽
pp. 704.13-704
Author(s):
M. Trachana
◽
P. Pratsidou-Gertsi
◽
O. Vougiouka
Keyword(s):
Juvenile Idiopathic Arthritis
◽
Systemic Juvenile Idiopathic Arthritis
◽
National Registry
◽
Safety And Efficacy
Download Full-text
Safety and efficacy of tocilizumab in children with systemic juvenile idiopathic arthritis
Pediatric Rheumatology
◽
10.1186/1546-0096-13-s1-p165
◽
2015
◽
Vol 13
(S1)
◽
Cited By ~ 1
Author(s):
G Horneff
◽
I Huppertz
◽
P Haas
◽
K Minden
◽
G Ganser
◽
...
Keyword(s):
Juvenile Idiopathic Arthritis
◽
Systemic Juvenile Idiopathic Arthritis
◽
Safety And Efficacy
Download Full-text
A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
Arthritis & Rheumatism
◽
10.1002/art.33342
◽
2012
◽
Vol 64
(2)
◽
pp. 557-567
◽
Cited By ~ 133
Author(s):
Nicolino Ruperto
◽
Pierre Quartier
◽
Nico Wulffraat
◽
Patricia Woo
◽
Angelo Ravelli
◽
...
Keyword(s):
Juvenile Idiopathic Arthritis
◽
Phase Ii
◽
Systemic Juvenile Idiopathic Arthritis
◽
Open Label
◽
Open Label Study
◽
Label Study
◽
Safety And Efficacy
Download Full-text
Long-term safety and efficacy of varicella vaccination in children with juvenile idiopathic arthritis treated with biologic therapy
Vaccine
◽
10.1016/j.vaccine.2015.06.086
◽
2015
◽
Vol 33
(33)
◽
pp. 4056-4059
◽
Cited By ~ 11
Author(s):
N. Toplak
◽
T. Avčin
Keyword(s):
Juvenile Idiopathic Arthritis
◽
Biologic Therapy
◽
Varicella Vaccination
◽
Safety And Efficacy
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close